Literature DB >> 24580777

Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance.

P Ingiliz1, I Krznaric, H-J Stellbrink, G Knecht, T Lutz, C Noah, H Stocker, M Obermeier, S Dupke, C Boesecke, J K Rockstroh, A Baumgarten, C Hoffmann.   

Abstract

OBJECTIVES: The incidence of sexually transmitted hepatitis C virus (HCV) reinfection is on the rise in HIV-infected men who have sex with men (MSM). Data on natural history of acute hepatitis C and possible factors associated with spontaneous clearance are limited. The aim of this study was to analyse the outcome of HCV reinfections in HIV-positive MSM.
METHODS: A retrospective analysis was carried out on patients with more than one sexually acquired HCV infection who were diagnosed at four major German HIV and hepatitis care centres. Reinfection was defined by genotype or phylogenetic clade switch, detectable HCV RNA after a sustained virological response (SVR) or after spontaneous clearance (SC).
RESULTS: In total, 48 HIV-positive MSM were identified with HCV reinfection, among them 11 with a third episode and one patient with four episodes. At the first episode, 43 and five patients had an SVR and SC, respectively. The second episode was accompanied by a genotype switch in 29 patients (60%). Whereas 30 and nine patients showed an SVR and SC, respectively, eight patients developed chronic hepatitis. Neither HCV genotype switch nor interleukin-28B genotype was associated with SC. However, SC rates at the second episode were higher for patients with SC at the first episode compared with patients without SC (60 vs. 14%, respectively; P = 0.03). Two patients with SC at the first episode were reinfected with the same genotype.
CONCLUSIONS: Multiple reinfections in HIV-infected MSM do occur, with or without genotype switch, and with prior SC of previous episodes. In this large case series, except for SC at the first episode, no factor was of value in clinical decision-making for early therapeutic intervention in acute HCV reinfection.
© 2014 British HIV Association.

Entities:  

Keywords:  HIV/HCV coinfection; IL-28B; reinfection; spontaneous clearance

Mesh:

Substances:

Year:  2014        PMID: 24580777     DOI: 10.1111/hiv.12127

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  11 in total

Review 1.  Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.

Authors:  O Falade-Nwulia; M S Sulkowski; A Merkow; C Latkin; S H Mehta
Journal:  J Viral Hepat       Date:  2018-03       Impact factor: 3.728

Review 2.  Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.

Authors:  Emma Kaplan-Lewis; Daniel Seth Fierer
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

3.  Hierarchical assessment of host factors influencing the spontaneous resolution of hepatitis C infection.

Authors:  Paola Jocelan Scarin Provazzi; Livia Maria Gonçalves Rossi; Bruno Moreira Carneiro; Valeria Chamas Miura; Plinio Cesar Rodrigues Rosa; Lucas Rodrigues de Carvalho; Stephane Tereza Queiroz de Andrade; Roberta Maria Fachini; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Carlos Roberto Valêncio; Paulo Scarpelini Neto; José Antonio Cordeiro; Mauricio Lacerda Nogueira; Paula Rahal
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

4.  Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis.

Authors:  Chrissa G Tsiara; Georgios K Nikolopoulos; Niki L Dimou; Katerina G Pantavou; Pantelis G Bagos; Benedicta Mensah; Michael Talias; Georgia G Braliou; Dimitra Paraskeva; Stefanos Bonovas; Angelos Hatzakis
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

5.  Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.

Authors:  Susanna Naggie; Kristen M Marks; Michael Hughes; Daniel S Fierer; Christine Macbrayne; Arthur Kim; Kimberly Hollabaugh; Jhoanna Roa; Bill Symonds; Diana M Brainard; John G McHutchison; Marion G Peters; Jennifer J Kiser; Raymond Chung
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

6.  HCV reinfection incidence among individuals treated for recent infection.

Authors:  M Martinello; J Grebely; K Petoumenos; E Gane; M Hellard; D Shaw; J Sasadeusz; T L Applegate; G J Dore; G V Matthews
Journal:  J Viral Hepat       Date:  2017-01-23       Impact factor: 3.728

Review 7.  Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.

Authors:  Holly Hagan; Ashly E Jordan; Joshua Neurer; Charles M Cleland
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

8.  High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.

Authors:  Josep Quer; Josep Gregori; Francisco Rodríguez-Frias; Maria Buti; Antonio Madejon; Sofia Perez-del-Pulgar; Damir Garcia-Cehic; Rosario Casillas; Maria Blasi; Maria Homs; David Tabernero; Miguel Alvarez-Tejado; Jose Manuel Muñoz; Maria Cubero; Andrea Caballero; Jose Antonio del Campo; Esteban Domingo; Irene Belmonte; Leonardo Nieto; Sabela Lens; Paloma Muñoz-de-Rueda; Paloma Sanz-Cameno; Silvia Sauleda; Marta Bes; Jordi Gomez; Carlos Briones; Celia Perales; Julie Sheldon; Lluis Castells; Lluis Viladomiu; Javier Salmeron; Angela Ruiz-Extremera; Rosa Quiles-Pérez; Ricardo Moreno-Otero; Rosario López-Rodríguez; Helena Allende; Manuel Romero-Gómez; Jaume Guardia; Rafael Esteban; Javier Garcia-Samaniego; Xavier Forns; Juan Ignacio Esteban
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

Review 9.  HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.

Authors:  Kian Bichoupan; Douglas T Dieterich; Valérie Martel-Laferrière
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.495

10.  High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.

Authors:  Klaus Jansen; Michael Thamm; Claus-Thomas Bock; Ramona Scheufele; Claudia Kücherer; Dieter Muenstermann; Hans-Jochen Hagedorn; Heiko Jessen; Stephan Dupke; Osamah Hamouda; Barbara Gunsenheimer-Bartmeyer; Karolin Meixenberger
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.